Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

Recruiting now · Not applicable

Conditions studied: Wrinkle, Scar, Laxity; Skin

In brief

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

Key facts

Study ID

NCT06336044

Run by

Taumedika s.r.l.

People needed

40

Starts

2026-02-01

Expected to finish

2026-06-01

Last updated by the study team

2026-01-26

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• all sexes
• caucasic
• 18 to 70 years
• non smoker

You may not qualify if…

• Pregnancy
• milking
• smoker
• alcohol or drugs abuse
• change of BMI during the study
• previous facial surgery, implants, permanent treatments
• sensitivity to the product
• dermatological difficult frame
• health weakness
• treated with anticoagulants, antihistaminics, corticosteroids, antidepressants and other drugs impacting on the results

Where it is running

• Ospedale Tor Vergata — Roma, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.